C Englisch , F Moik , J Thaler , S Koder , M Preusser , I Pabinger , C Ay.
Tissue Factor Pathway Inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer
GTH Congress 2023 – 67th Annual Meeting of the Society of Thrombosis and Haemostasis Research. 2023; 43(S01):S23--67th Annual Meeting of the Society of Thrombosis and Haemostasis Research; Feb 21-24, 2023; Frankfurt, Germany.
[Oral Communication]
FullText